Arthromax w/Theaflavins and Apresflex – 120 capsules

As you grow older, age-related stiffness and discomfort in the joints becomes a fact of life. Activities once routine become a challenge as limited mobility hampers your every move.

Inflammatory reactions are regulated by a series of “cytokines” produced in the body. Normal aging results in an unfavorable balance of these cytokines that contributes to persistent inflammatory conditions. Studies have shown that a special fraction found in black tea suppresses proinflammatory cytokines at the genomic level. Scientists have found that these com­pounds called theaflavins uniquely downregulate the expression of genes associated with inflammatory cytokines.1

ArthroMax® with Theaflavins & AprèsFlex® provides bioactive theaflavin fractions, along with MSM (methylsulfonylmethane), which contains sulfur components that are critically important in maintain­ing comfortable joint function.2-4 It also contains FruiteX B® OsteoBoron®, a patented form of boron identical to natural plant forms found in food. Considered more bioavail­able than other forms of boron, FruiteX B® OsteoBoron® also supports healthy bones and joints.5-7

AprèsFlex® represents a quantum leap forward in the delivery of boswellia to aging joints. Long prized for its ability to help inhibit inflammatory factors, boswellia is especially effective at inhibiting the 5-LOX (5-lipoxygenase) enzyme.

Excess activity of 5-LOX results in the accumulation of leukotriene B4, a pro-inflammatory compound that affects aging joints. Boswellia has been shown to bind directly to the 5-LOX enzyme, preventing it from facilitating production of pro-inflammatory leukotrienes.8, 9

AprèsFlex® boswellia absorbs into the blood 52% better than previously available forms of boswellia, for superior effectiveness.10

References

1. Mol Nutr Foods Res 2006 Feb;50(2):115-22.
2. Adv Ther. 2011 Oct;28(10):894-906. 
3. Acta Vet Scand. 2008 Nov 7;50:45. 
4. Nutr J. 2008 Oct 27;7:31. 
5. Miljkovic D (1999) Boron and carbohydrate complexes and uses thereof. U.S. Patent # 5, 962, 049. 
6. Miljkovic ND, Miljkovic DA, Ercegan GM (2002) Osteoarthritis and Calcium Fructoborate Supplementation: An Open-Label Study. FutureCeuticals Internal Study. 
7. Available at: http://www.futureceuticals.com/pdfs/r_d_section/fc_research_page/ by_product/fruitex_b/5._fruitexb_increases_bone_density-r_d.pdf Accessed December 17, 2012.
8. Wien Med Wochenschr. 2002;152(15-16):373-8. 
9. J Ethnopharmacol. 2006 Sep 19;107(2):249-53.
10. Mol Cell Biochem. 2011 Aug;354(1-2):189-97.